NCT03067363View on ClinicalTrials.gov

First in Human Single Ascending Dose Study of MOR107

PHASE1TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 16, 2017

Primary Completion Date

March 23, 2017

Study Completion Date

March 23, 2017

Conditions
Safety
Interventions
DRUG

MOR107

MOR107 solution for injection

DRUG

Placebo

Solution for injection manufactured to match MOR107 solution for injection

OTHER

Low sodium diet

Diet designed to restrict sodium intake to 40 mmol/day

Trial Locations (1)

NG11 6JS

Quotient Clinical, Nottingham

Sponsors

Collaborators (1)

Quotient Clinical
All Listed Sponsors
collaborator

Quotient Clinical

OTHER

lead

Alan Richardson

INDUSTRY

NCT03067363 - First in Human Single Ascending Dose Study of MOR107 | Biotech Hunter | Biotech Hunter